Physician
Imperial Medical, PC
Imperial Medical, PC was paid $346K by Medicaid between Jan 2018 and Dec 2023, across 142 billing codes. Its largest line is G0447, Face-to-face behavioral counseling for obesity, 15 minutes — 15% of everything it billed.
33Billing provider infoIMPERIAL MEDICAL, PC
NEW YORK, NY 10040
NEW YORK, NY 10040
33aNPI1891937157assigned 04/01/2009
33bProvider typeInternal Medicine Physician
28Total paid$346K
24GClaims191,950
24DCodes billed142
24AFirst – last monthJan 2018 – Dec 2023
Compared with peers
Next to other Internal Medicine Physician providers in New York
Rank by total paid#600 of 6,049
Median peer was paid$11K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 33,800 | $77K | |
| 2019 | 62,906 | $110K | |
| 2020 | 63,244 | $114K | |
| 2021 | 16,409 | $37K | |
| 2022 | 9,713 | $5K | |
| 2023 | 5,878 | $4K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 15% | 3,378 | 3,302 | $51K |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 13% | 1,628 | 1,619 | $47K |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 11% | 3,596 | 2,966 | $40K |
| G0444 | Annual depression screening, 5 to 15 minutes | 9.4% | 2,572 | 2,542 | $33K |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 9.3% | 2,631 | 1,848 | $32K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.1% | 2,513 | 2,472 | $31K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 6.9% | 1,528 | 1,513 | $24K |
| 97802 | 5.0% | 3,388 | 2,186 | $17K | |
| 99442 | 4.9% | 3,796 | 3,587 | $17K | |
| H0049 | Alcohol and/or drug screening | 2.3% | 2,135 | 2,109 | $8K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 1.3% | 2,925 | 2,309 | $4K |
| 3079F | 1.2% | 2,261 | 2,226 | $4K |
130 more codes
| 3074F | 1.1% | 2,717 | $4K | |
| 99401 | <1% | 767 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 424 | $3K |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 5,179 | $3K |
| 1126F | <1% | 4,039 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,528 | $2K |
| S9470 | Nutritional counseling, dietitian visit | <1% | 3,214 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 130 | $2K |
| 82962 | <1% | 2,944 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,100 | $1K |
| 82274 | <1% | 238 | $1K | |
| 96127 | <1% | 2,671 | $1K | |
| 36410 | <1% | 286 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 12 | $834.88 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 1,306 | $720.00 |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 1,323 | $664.24 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 24 | $635.22 |
| 96160 | <1% | 1,543 | $625.96 | |
| G9665 | Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy | <1% | 259 | $564.85 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 12 | $500.39 |
| 99385 | <1% | 12 | $448.07 | |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | <1% | 1,149 | $425.10 |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 12 | $408.50 |
| 3048F | <1% | 813 | $360.00 | |
| 3050F | <1% | 734 | $328.00 | |
| 0521F | <1% | 1,567 | $320.00 | |
| 3061F | <1% | 828 | $304.00 | |
| 1125F | <1% | 657 | $300.00 | |
| 82270 | <1% | 373 | $276.30 | |
| 82272 | <1% | 346 | $264.74 | |
| 99386 | <1% | 12 | $248.48 | |
| 81000 | <1% | 2,611 | $247.75 | |
| 99408 | <1% | 1,709 | $237.46 | |
| 3049F | <1% | 526 | $144.00 | |
| 3078F | <1% | 730 | $130.00 | |
| 82948 | <1% | 1,201 | $114.84 | |
| H0001 | Alcohol and/or drug assessment | <1% | 3,056 | $94.93 |
| 99497 | <1% | 13 | $93.54 | |
| 97803 | <1% | 14 | $88.02 | |
| 86480 | <1% | 62 | $75.00 | |
| 3044F | <1% | 136 | $56.00 | |
| 0513F | <1% | 366 | $40.00 | |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | <1% | 3,211 | $37.50 |
| 81003 | <1% | 2,012 | $9.51 | |
| 1157F | <1% | 25 | $8.00 | |
| 1158F | <1% | 517 | $8.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,150 | $7.28 |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | <1% | 2,896 | $4.73 |
| 82947 | <1% | 250 | $1.65 | |
| H0003 | Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs | <1% | 855 | $1.64 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | <1% | 240 | $1.56 |
| 86703 | <1% | 1,635 | $1.48 | |
| 84442 | <1% | 2,065 | $1.08 | |
| 84479 | <1% | 1,807 | $1.01 | |
| 82043 | <1% | 2,406 | $0.83 | |
| 83719 | <1% | 1,974 | $0.81 | |
| 86592 | <1% | 1,761 | $0.67 | |
| 4010F | <1% | 2,328 | $0.63 | |
| 3008F | <1% | 3,930 | $0.62 | |
| 4210F | <1% | 2,307 | $0.52 | |
| 3066F | <1% | 1,065 | $0.43 | |
| 2022F | <1% | 975 | $0.34 | |
| 80053 | Comprehensive metabolic panel | <1% | 2,276 | $0.22 |
| 82040 | <1% | 1,988 | $0.17 | |
| 80061 | Lipid panel | <1% | 2,057 | $0.12 |
| 84520 | <1% | 1,930 | $0.11 | |
| 82565 | <1% | 1,966 | $0.09 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,801 | $0.07 |
| 86803 | <1% | 222 | $0.07 | |
| 86709 | <1% | 220 | $0.07 | |
| 87522 | Neg quan hep c or qual rna | <1% | 224 | $0.06 |
| 84152 | <1% | 28 | $0.06 | |
| 3045F | <1% | 144 | $0.03 | |
| 80051 | <1% | 2,269 | $0.02 | |
| 86705 | <1% | 223 | $0.01 | |
| 3014F | 0% | 2,226 | $0.00 | |
| 4144F | 0% | 174 | $0.00 | |
| 3754F | 0% | 1,959 | $0.00 | |
| 84132 | 0% | 484 | $0.00 | |
| G9912 | Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy | 0% | 3,189 | $0.00 |
| 1000F | 0% | 4,096 | $0.00 | |
| G9275 | Documentation that patient is a current non-tobacco user | 0% | 4,798 | $0.00 |
| 4060F | 0% | 317 | $0.00 | |
| 84480 | 0% | 394 | $0.00 | |
| 3011F | 0% | 5,020 | $0.00 | |
| 1170F | 0% | 144 | $0.00 | |
| 1036F | 0% | 3,840 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 2,613 | $0.00 |
| 82575 | 0% | 420 | $0.00 | |
| 2001F | 0% | 2,561 | $0.00 | |
| 3017F | 0% | 1,920 | $0.00 | |
| 86706 | 0% | 221 | $0.00 | |
| G9226 | Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) | 0% | 1,717 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 191 | $0.00 |
| G9667 | Documentation of medical reason(s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy) | 0% | 269 | $0.00 |
| 4140F | 0% | 155 | $0.00 | |
| G8725 | Fasting lipid profile performed (triglycerides, ldl-c, hdl-c and total cholesterol) | 0% | 60 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 12 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 119 | $0.00 |
| 80069 | 0% | 406 | $0.00 | |
| 87110 | 0% | 74 | $0.00 | |
| 2016F | 0% | 37 | $0.00 | |
| 1005F | 0% | 24 | $0.00 | |
| 2015F | 0% | 24 | $0.00 | |
| 3016F | 0% | 2,961 | $0.00 | |
| 3725F | 0% | 3,383 | $0.00 | |
| 1159F | 0% | 739 | $0.00 | |
| G9383 | Patient received screening for hcv infection within the 12 month reporting period | 0% | 1,324 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 367 | $0.00 |
| 4064F | 0% | 339 | $0.00 | |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 335 | $0.00 |
| 1033F | 0% | 3,088 | $0.00 | |
| G8506 | Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy | 0% | 728 | $0.00 |
| 3085F | 0% | 819 | $0.00 | |
| 1090F | 0% | 1,871 | $0.00 | |
| 90399 | 0% | 217 | $0.00 | |
| 2028F | 0% | 2,074 | $0.00 | |
| G8404 | Lower extremity neurological exam performed and documented | 0% | 103 | $0.00 |
| 3015F | 0% | 1,393 | $0.00 | |
| 4062F | 0% | 238 | $0.00 | |
| 83721 | 0% | 347 | $0.00 | |
| 2014F | 0% | 812 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 2,586 | $0.00 |
| 1160F | 0% | 739 | $0.00 | |
| 0403T | 0% | 180 | $0.00 | |
| 3288F | 0% | 25 | $0.00 | |
| 1494F | 0% | 12 | $0.00 | |
| 5250F | 0% | 24 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 14 | $0.00 |
| 3046F | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBULA, ELSA (ADMINISTRATOR)